fluorouracil has been researched along with Abdominal Neoplasms in 47 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Abdominal Neoplasms: New abnormal growth of tissue in the ABDOMEN.
| Excerpt | Relevance | Reference |
|---|---|---|
| "5-fluorouracil remains the standard therapy for patients with advanced/metastatic colorectal cancer." | 9.10 | Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer--a phase II study. ( Blackstock, AW; Case, D; Higgs, V; Melin, SA; Savage, P; Tomlinson, SK; White, DR, 2002) |
| "Capecitabine is an orally administered precursor of 5'-deoxy-5-fluorouridine that was rationally designed to generate 5-fluorouracil (5-FU) preferentially in tumor tissue." | 6.73 | Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer. ( Alessandroni, P; Baldelli, AM; Casadei, V; Catalano, G; Catalano, V; Ceccolini, M; Fedeli, A; Fedeli, SL; Giordani, P; Rossi, D, 2007) |
| "Sixteen patients with metastatic colorectal cancer have been treated with a regimen involving an 120 h continuous infusion of rIL-2, 18 x 10(6) iu m-2 day followed by three injections of 5FU 600 mg m-2 at weekly intervals." | 6.67 | A phase-III study of recombinant interleukin 2 and 5-fluorouracil chemotherapy in patients with metastatic colorectal cancer. ( Franks, CR; Hamblin, TJ; Oskam, R; Palmer, P; Sadullah, S; Stevenson, J; Williamson, P, 1993) |
| "5-fluorouracil remains the standard therapy for patients with advanced/metastatic colorectal cancer." | 5.10 | Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer--a phase II study. ( Blackstock, AW; Case, D; Higgs, V; Melin, SA; Savage, P; Tomlinson, SK; White, DR, 2002) |
| "A total of 185 patients with gastric cancer and abdominal lymph node metastasis were enrolled and divided into 2 groups: group A received chemotherapy alone (n = 102); group B received HIFU combined with chemotherapy (n = 83)." | 2.80 | Effects of high-intensity focused ultrasound for treatment of abdominal lymph node metastasis from gastric cancer. ( Liu, L; Liu, P; Lu, K; Shu, Y; Wang, J; Wang, R; Zhang, M, 2015) |
| "Capecitabine is an orally administered precursor of 5'-deoxy-5-fluorouridine that was rationally designed to generate 5-fluorouracil (5-FU) preferentially in tumor tissue." | 2.73 | Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer. ( Alessandroni, P; Baldelli, AM; Casadei, V; Catalano, G; Catalano, V; Ceccolini, M; Fedeli, A; Fedeli, SL; Giordani, P; Rossi, D, 2007) |
| " The pharmacokinetic advantage of 5-FU-ip was confirmed in our study (ratio AUC peritoneum/plasma between 160 and 328)." | 2.67 | [Continuous double administration of 5 fluorouracil (intravenous and intraperitoneal) modulated by folinic acid: phase I clinical study and pharmacokinetics in patients with intra-abdominal developing cancers]. ( Bugat, R; Canal, P; Chevreau, C; de Forni, M; Gualano, V; Izar-Soum, F; Martel, P; Roché, H; Soulié, P, 1993) |
| "Sixteen patients with metastatic colorectal cancer have been treated with a regimen involving an 120 h continuous infusion of rIL-2, 18 x 10(6) iu m-2 day followed by three injections of 5FU 600 mg m-2 at weekly intervals." | 2.67 | A phase-III study of recombinant interleukin 2 and 5-fluorouracil chemotherapy in patients with metastatic colorectal cancer. ( Franks, CR; Hamblin, TJ; Oskam, R; Palmer, P; Sadullah, S; Stevenson, J; Williamson, P, 1993) |
| "Local recurrence was diagnosed 5 years and 4 months after the operation." | 1.43 | [A Patient with Colon Cancer Local Site Recurrence Who Experienced Difficulty Tolerating Intensive Chemotherapy Was Treated Effectively with sLV5FU2 Therapy]. ( Fukunaga, M; Honda, S; Kobayashi, K; Konishi, K; Miki, H; Okada, K; Ota, H; Saito, A; Tokuyama, S; Yokoyama, S; Yoshioka, S; Yukimoto, R, 2016) |
| "For patients with HER2-overexpressing gastric cancer, there is an improved prognosis with additional trastuzumab to chemotherapy with a platinum compound and a fluoropyrimidin in first-line therapy." | 1.37 | Successful treatment of a patient with HER2-positive metastatic gastric cancer with third-line combination therapy with irinotecan, 5-fluorouracil, leucovorin and trastuzumab (FOLFIRI-T). ( Dumke, K; Krüger, M; Reymond, M; Weissinger, F, 2011) |
| "5 Gy, representing a dose deposited in the generous, off-target area in clinical practice, resulted in a similar pharmacokinetic profile, with a 21." | 1.36 | Abdominal irradiation modulates 5-Fluorouracil pharmacokinetics. ( Chen, YJ; Hsieh, CH; Hsieh, YJ; Huang, YC; Liu, CY; Shueng, PW; Tai, HC; Tsai, TH; Wang, LY; Wu, LJ, 2010) |
| "A 60-year-old woman with gastric cancer had undergone partial gastrectomy in September 1989." | 1.28 | Complete disappearance of metastatic abdominal tumors from gastric cancer after treatment with irsogladine maleate. ( Hosokawa, T; Kajiwara, T; Ogawa, K; Otani, Y, 1992) |
| "The risk of superinfection following routine abdominal drainage after major surgery is debated." | 1.28 | Implantable drainage after major abdominal surgery in compromised patients. ( Andersson, R; Bengmark, S; Holmberg, A; Jeppsson, B, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (44.68) | 18.7374 |
| 1990's | 10 (21.28) | 18.2507 |
| 2000's | 12 (25.53) | 29.6817 |
| 2010's | 4 (8.51) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, M | 1 |
| Liu, L | 1 |
| Wang, J | 1 |
| Lu, K | 1 |
| Shu, Y | 1 |
| Wang, R | 1 |
| Liu, P | 1 |
| Yoshioka, S | 1 |
| Fukunaga, M | 1 |
| Tokuyama, S | 1 |
| Honda, S | 1 |
| Yukimoto, R | 1 |
| Saito, A | 1 |
| Okada, K | 1 |
| Konishi, K | 1 |
| Ota, H | 1 |
| Yokoyama, S | 1 |
| Miki, H | 1 |
| Kobayashi, K | 1 |
| Hsieh, CH | 1 |
| Hsieh, YJ | 1 |
| Liu, CY | 1 |
| Tai, HC | 1 |
| Huang, YC | 1 |
| Shueng, PW | 1 |
| Wu, LJ | 1 |
| Wang, LY | 1 |
| Tsai, TH | 1 |
| Chen, YJ | 1 |
| Weissinger, F | 1 |
| Reymond, M | 1 |
| Dumke, K | 1 |
| Krüger, M | 1 |
| Wright, MA | 1 |
| Schuler, B | 1 |
| Szabo, E | 1 |
| Grem, JL | 1 |
| NORA, PF | 1 |
| KUKRAL, JC | 1 |
| PRESTON, FW | 1 |
| RIEHL, JL | 1 |
| BROWN, WJ | 1 |
| Levitz, JS | 1 |
| Sugarbaker, PH | 2 |
| Lichtman, SM | 1 |
| Brun, EA | 1 |
| Leitman, M | 1 |
| Baram, S | 1 |
| Sidenko, S | 1 |
| Abo-Kishk, I | 1 |
| Peleg, E | 1 |
| Vered, Z | 1 |
| Tytherleigh, MG | 1 |
| Birtle, AJ | 1 |
| Cohen, CE | 1 |
| Glynne-Jones, R | 1 |
| Livingstone, J | 1 |
| Gilbert, J | 1 |
| Schneider, BJ | 1 |
| El-Rayes, B | 1 |
| Muler, JH | 1 |
| Philip, PA | 1 |
| Kalemkerian, GP | 1 |
| Griffith, KA | 1 |
| Zalupski, MM | 1 |
| Rossi, D | 1 |
| Alessandroni, P | 1 |
| Catalano, V | 1 |
| Giordani, P | 1 |
| Fedeli, SL | 1 |
| Fedeli, A | 1 |
| Baldelli, AM | 1 |
| Casadei, V | 1 |
| Ceccolini, M | 1 |
| Catalano, G | 1 |
| Karakousis, CP | 1 |
| de Forni, M | 1 |
| Gualano, V | 1 |
| Canal, P | 1 |
| Martel, P | 1 |
| Izar-Soum, F | 1 |
| Chevreau, C | 1 |
| Soulié, P | 1 |
| Roché, H | 1 |
| Bugat, R | 1 |
| Hamblin, TJ | 1 |
| Sadullah, S | 1 |
| Williamson, P | 1 |
| Stevenson, J | 1 |
| Oskam, R | 1 |
| Palmer, P | 1 |
| Franks, CR | 1 |
| Pazdur, R | 1 |
| Ajani, JA | 1 |
| Patt, YZ | 1 |
| Gomez, J | 1 |
| Bready, B | 1 |
| Levin, B | 1 |
| Ben-Ari, GY | 1 |
| Berkenstadt, H | 1 |
| Ben-Ari, G | 2 |
| Perel, A | 1 |
| Cavaliere, F | 1 |
| Di Filippo, F | 1 |
| Cosimelli, M | 1 |
| Aloe, L | 1 |
| Arcuri, E | 1 |
| Anzà, M | 1 |
| Callopoli, A | 1 |
| Di Lauro, L | 1 |
| Morace, E | 1 |
| Botti, C | 1 |
| Natoli, S | 1 |
| Tedesco, M | 1 |
| Giunta, S | 1 |
| Cavaliere, R | 1 |
| Yoshioka, T | 1 |
| Fukuda, H | 1 |
| Fujiwara, T | 1 |
| Iwata, R | 1 |
| Ido, T | 1 |
| Murakawa, Y | 1 |
| Gamo, M | 1 |
| Ishioka, C | 1 |
| Kanamaru, R | 1 |
| Tocchi, A | 1 |
| Lepre, L | 1 |
| Costa, G | 1 |
| Liotta, G | 1 |
| Mazzoni, G | 1 |
| Agostini, N | 1 |
| Miccini, M | 1 |
| Scott, D | 1 |
| Zippel, D | 1 |
| Sareli, M | 1 |
| Koller, M | 1 |
| Papa, M | 1 |
| Foa, C | 1 |
| Bondiau, PY | 1 |
| Largillier, R | 1 |
| Milano, G | 1 |
| Magné, N | 1 |
| Witte, RS | 1 |
| Cnaan, A | 1 |
| Mansour, EG | 1 |
| Barylak, E | 1 |
| Harris, JE | 1 |
| Schutt, AJ | 1 |
| Guseinov, E | 1 |
| Horák, D | 1 |
| Titova, M | 1 |
| Adamyan, A | 1 |
| Kokov, L | 1 |
| Kubishkin, V | 1 |
| Vishnevskii, V | 1 |
| Skuba, N | 1 |
| Trostenyuk, N | 1 |
| Heidemann, J | 1 |
| Gockel, HR | 1 |
| Winde, G | 1 |
| Herbst, H | 1 |
| Domschke, W | 1 |
| Lügering, N | 1 |
| Tomlinson, SK | 1 |
| Melin, SA | 1 |
| Higgs, V | 1 |
| White, DR | 1 |
| Savage, P | 1 |
| Case, D | 1 |
| Blackstock, AW | 1 |
| Samuels, ML | 1 |
| Holoye, PY | 1 |
| Johnson, DE | 1 |
| Ramming, KP | 1 |
| Sparks, FC | 1 |
| Eilber, FR | 1 |
| Morton, DL | 1 |
| Hosokawa, T | 1 |
| Otani, Y | 1 |
| Ogawa, K | 1 |
| Kajiwara, T | 1 |
| Andersson, R | 1 |
| Jeppsson, B | 1 |
| Holmberg, A | 1 |
| Bengmark, S | 1 |
| Francini, G | 1 |
| Lorenzini, L | 1 |
| Armenio, S | 1 |
| Gennari, C | 1 |
| Klausner, JM | 2 |
| Gutman, M | 1 |
| Rozin, RR | 1 |
| Lelcuk, S | 2 |
| Chaitchik, S | 1 |
| Inbar, M | 2 |
| Norton, JA | 1 |
| Doppman, JL | 1 |
| Wesley, RA | 1 |
| Maton, PN | 1 |
| Gardner, JD | 1 |
| Jensen, RT | 1 |
| Arbuck, SG | 1 |
| Trave, F | 1 |
| Douglass, HO | 1 |
| Nava, H | 1 |
| Zakrzewski, S | 1 |
| Rustum, YM | 1 |
| Brenner, DE | 1 |
| Braly, P | 1 |
| Doroshow, J | 1 |
| Hoff, S | 1 |
| Arai, Y | 1 |
| Kido, C | 1 |
| Ota, K | 1 |
| Endo, T | 1 |
| Suyama, K | 1 |
| Rozin, R | 1 |
| Kaibara, N | 1 |
| Wakasugi, K | 1 |
| Kumashiro, R | 1 |
| Inokuchi, K | 1 |
| Holsti, LR | 1 |
| Nordman, E | 1 |
| Griffen, WO | 1 |
| Humphrey, L | 1 |
| Sosin, H | 1 |
| Kobayashi, T | 1 |
| Takatani, O | 1 |
| Hattori, N | 1 |
| Kimura, K | 1 |
| Watt, J | 1 |
| Rozhold, J | 1 |
| Klucár, J | 1 |
| Meriwether, WD | 1 |
| Ramsey, HE | 1 |
| Ward, SP | 1 |
| Wirtanen, GW | 1 |
| Bernhardt, LC | 1 |
| Mackman, S | 1 |
| Ramirez, G | 1 |
| Curreri, AR | 1 |
| Ansfield, FJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase I Study of Weekly Gemcitabine in Combination With Infusional 5-Fluorouracil and Oral Calcium Leucovorin in Adult Cancer Patients[NCT00019513] | Phase 1 | 108 participants (Anticipated) | Interventional | 1998-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for fluorouracil and Abdominal Neoplasms
| Article | Year |
|---|---|
Intraperitoneal chemotherapy: a review.
Topics: Abdominal Neoplasms; Antineoplastic Agents; Cisplatin; Clinical Trials as Topic; Cytarabine; Doxorub | 1986 |
The prognosis and management of recurrent abdominal malignancies.
Topics: Abdominal Neoplasms; Adolescent; Adult; Antineoplastic Agents; Bile Duct Neoplasms; Chemotherapy, Ca | 1969 |
The use of cytotoxic drugs in the surgery of malignant disease.
Topics: Abdominal Neoplasms; Alkylating Agents; Animals; Antimetabolites; Antineoplastic Agents; Carcinoma, | 1968 |
9 trials available for fluorouracil and Abdominal Neoplasms
| Article | Year |
|---|---|
Effects of high-intensity focused ultrasound for treatment of abdominal lymph node metastasis from gastric cancer.
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Combined Modal | 2015 |
Phase II trial of carboplatin, gemcitabine, and capecitabine in patients with carcinoma of unknown primary site.
Topics: Abdominal Neoplasms; Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Capecitabi | 2007 |
Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer.
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Breast Neoplas | 2007 |
[Continuous double administration of 5 fluorouracil (intravenous and intraperitoneal) modulated by folinic acid: phase I clinical study and pharmacokinetics in patients with intra-abdominal developing cancers].
Topics: Abdominal Neoplasms; Drug Synergism; Female; Fluorouracil; Humans; Infusions, Intravenous; Injection | 1993 |
A phase-III study of recombinant interleukin 2 and 5-fluorouracil chemotherapy in patients with metastatic colorectal cancer.
Topics: Abdominal Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capillary Permeabi | 1993 |
Phase II evaluation of recombinant alpha-2a-interferon and continuous infusion fluorouracil in previously untreated metastatic colorectal adenocarcinoma.
Topics: Abdominal Neoplasms; Adenocarcinoma; Adult; Aged; Colonic Neoplasms; Drug Administration Schedule; F | 1993 |
Comparison of 5-fluorouracil alone, 5-fluorouracil with levamisole, and 5-fluorouracil with hepatic irradiation in the treatment of patients with residual, nonmeasurable, intra-abdominal metastasis after undergoing resection for colorectal carcinoma.
Topics: Abdominal Neoplasms; Adjuvants, Immunologic; Adult; Aged; Aged, 80 and over; Antineoplastic Combined | 2001 |
Schedule-selective biochemical modulation of 5-fluorouracil in advanced colorectal cancer--a phase II study.
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; | 2002 |
Intraperitoneal chemotherapy: a review.
Topics: Abdominal Neoplasms; Antineoplastic Agents; Cisplatin; Clinical Trials as Topic; Cytarabine; Doxorub | 1986 |
36 other studies available for fluorouracil and Abdominal Neoplasms
| Article | Year |
|---|---|
[A Patient with Colon Cancer Local Site Recurrence Who Experienced Difficulty Tolerating Intensive Chemotherapy Was Treated Effectively with sLV5FU2 Therapy].
Topics: Abdominal Neoplasms; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil | 2016 |
Abdominal irradiation modulates 5-Fluorouracil pharmacokinetics.
Topics: Abdominal Neoplasms; Animals; Antimetabolites, Antineoplastic; Area Under Curve; Cholangiocarcinoma; | 2010 |
Successful treatment of a patient with HER2-positive metastatic gastric cancer with third-line combination therapy with irinotecan, 5-fluorouracil, leucovorin and trastuzumab (FOLFIRI-T).
Topics: Abdominal Neoplasms; Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy | 2011 |
Sustained partial response of an intra-abdominal desmoid tumor treated with gemcitabine, 5-fluorouracil and leucovorin.
Topics: Abdominal Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Fibromatos | 2003 |
INFUSION CHEMOTHERAPY FOR ABDOMINAL MALIGNANCIES. METHODOLOGY AND PRELIMINARY REPORT.
Topics: Abdominal Neoplasms; Angiography; Antimetabolites; Antineoplastic Agents; Aorta; Aorta, Abdominal; B | 1964 |
ACUTE CEREBELLAR SYNDROME SECONDARY TO 5-FLUOROURACIL THERAPY.
Topics: Abdominal Neoplasms; Adenocarcinoma; Bone Neoplasms; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, | 1964 |
Unusual abdominal tumors, case 1. Pseudomyxoma peritonei: response to capecitabine.
Topics: Abdominal Neoplasms; Adenocarcinoma, Mucinous; Appendiceal Neoplasms; Capecitabine; Deoxycytidine; F | 2004 |
Transient left ventricular and right atrial thrombosis after 5-fluorouracil therapy.
Topics: Abdominal Neoplasms; Adolescent; Carcinoma, Signet Ring Cell; Echocardiography; Fluorouracil; Heart | 2004 |
Combined surgery and chemoradiation as a treatment for the Buschke-Löwenstein tumour.
Topics: Abdominal Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinom | 2006 |
The abdominoinguinal incision in limb salvage and resection of pelvic tumors.
Topics: Abdominal Muscles; Abdominal Neoplasms; Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy P | 1984 |
Treatment of abdominal malignancies using total abdominal stop-flow infusion and hypoxic perfusion.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, | 1997 |
Hemodynamic changes during a new procedure for regional chemotherapy involving occlusion of the thoracic aorta and inferior vena cava.
Topics: Abdominal Neoplasms; Adult; Aged; Anesthesia, General; Antibiotics, Antineoplastic; Antimetabolites, | 1998 |
The integrated treatment of peritoneal carcinomatosis. A preliminary experience.
Topics: Abdominal Neoplasms; Adolescent; Adult; Aged; Carcinoma; Chemotherapy, Adjuvant; Chemotherapy, Cance | 1999 |
FDG PET evaluation of residual masses and regrowth of abdominal lymph node metastases from colon cancer compared with CT during chemotherapy.
Topics: Abdominal Neoplasms; Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, | 1999 |
Rectal cancer and inguinal metastases: prognostic role and therapeutic indications.
Topics: Abdominal Neoplasms; Adenocarcinoma; Aged; Aged, 80 and over; Biopsy; Female; Fluorouracil; Follow-U | 1999 |
Continuous hyperthermic peritoneal perfusion (CHPP) for malignant ascites and irresectable intra-abdominal cancer.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Ascites; Cell Division; Cisplat | 2000 |
[Dihydropyrimidine dehydrogenase deficiency and 5-fluorouracil toxicity].
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dihydrouracil Dehydr | 2000 |
Endovascular occlusion of branches of hepatic artery with poly(2-hydroxyethyl methacrylate) emboli as a single occlusive measure in hepatology.
Topics: Abdominal Neoplasms; Adolescent; Adult; Aged; Arterial Occlusive Diseases; Carcinoid Tumor; Carcinom | 2000 |
Signet-ring cell carcinoma of unknown primary location. Metastatic to lower back musculature - remission following FU/FA chemotherapy.
Topics: Abdominal Neoplasms; Aged; Back; Biopsy, Needle; Carcinoma, Signet Ring Cell; Diagnosis, Differentia | 2002 |
Bleomycin combination chemotherapy in the management of testicular neoplasia.
Topics: Abdominal Neoplasms; Adult; Bleomycin; Cyclophosphamide; Drug Therapy, Combination; Dysgerminoma; Fl | 1975 |
Management of hepatic metastases.
Topics: Abdominal Neoplasms; Adult; Aged; Antineoplastic Agents; Carcinoma; Chemotherapy, Cancer, Regional P | 1977 |
Complete disappearance of metastatic abdominal tumors from gastric cancer after treatment with irsogladine maleate.
Topics: Abdominal Neoplasms; Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Pro | 1992 |
Implantable drainage after major abdominal surgery in compromised patients.
Topics: Abdominal Neoplasms; Adult; Aged; Bacterial Infections; Drainage; Female; Fluorouracil; Humans; Immu | 1990 |
Palliative chemotherapy for relief of subocclusive symptoms.
Topics: Abdominal Neoplasms; Drug Therapy, Combination; Fluorouracil; Folic Acid; Humans; Palliative Care; P | 1987 |
Conventional fractionation radiotherapy combined with 5-fluorouracil for metastatic malignant melanoma.
Topics: Abdominal Neoplasms; Adult; Aged; Cobalt Radioisotopes; Female; Fluorouracil; Humans; Liver Neoplasm | 1987 |
Aggressive resection of metastatic disease in selected patients with malignant gastrinoma.
Topics: Abdominal Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cimetidine; Combin | 1986 |
Phase I and pharmacologic studies of intraperitoneal leucovorin and 5-fluorouracil in patients with advanced cancer.
Topics: Abdominal Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Catheterization; Drug Ev | 1986 |
Technical aspects of intraperitoneal chemotherapy in abdominal carcinomatosis.
Topics: Abdominal Neoplasms; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherap | 1986 |
[Intra-arterial infusion chemotherapy using a subcutaneously implanted silicone reservoir--with reference to the chemotherapy protocol].
Topics: Abdominal Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Catheterization; Cytarabi | 1985 |
The effects of perioperative fluorouracil administration on convalescence and wound healing.
Topics: Abdominal Neoplasms; Aged; Female; Fluorouracil; Humans; Intestines; Intraoperative Care; Male; Post | 1986 |
Enhancing effect of clamping of the portal vein on the effectiveness of antitumor agents against abdominal tumor growth.
Topics: Abdominal Neoplasms; Animals; Antineoplastic Agents; Bleomycin; Female; Fluorouracil; Injections, In | 1974 |
The value of radiotherapy in the treatment of carcinoma of the colon.
Topics: Abdominal Neoplasms; Colonic Neoplasms; Denmark; Female; Finland; Fluorouracil; Humans; Male; Neopla | 1966 |
Echographic evaluation of abdominal tumor regression during antineoplastic treatment.
Topics: Abdominal Neoplasms; Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Cyclophosphamide; Doxorub | 1974 |
[Cytostatics in the regional chemotherapy of malignant tumors of the abdominal organs and of their liver metastases].
Topics: Abdominal Neoplasms; Chemotherapy, Cancer, Regional Perfusion; Female; Fluorouracil; Humans; Liver N | 1974 |
Embryonal cell carcinoma of the ovary. Report of a case.
Topics: Abdominal Neoplasms; Adolescent; Age Factors; Black People; Cyclophosphamide; Drug Therapy, Combinat | 1971 |
Hepatic artery and celiac axis infusion for the treatment of upper abdominal malignant lesions.
Topics: Abdominal Neoplasms; Carcinoma; Celiac Artery; Fluorouracil; Gastrointestinal Neoplasms; Head and Ne | 1968 |